Vous êtes ici

InnoCan Pharma Corporation

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
INNO
Indice CSE: 
Devise: 

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

Vous êtes ici

InnoCan Pharma Corporation (INNO)

SEDAR Information

Information d'entreprise

Addresse
10 Hamenofim Street
Herzliya 4672561
Israël
Téléphone
972-54-301-2842
Courriel
irisb@innocanpharma.com
URL
http://innocanpharma.com
Date d’inscription à la cote
Mardi, septembre 24, 2019
Agent de transfert
Odyssey Trust Company

Advertisement

Publicité

Capitalisation

Capitalisation: 
143,866,169
Réservé à l'émission: 
22,666,583

Bulletins

Advertisement

Publicité

Latest CSE News

Évènements à venir

01_19_Vancouver_Resource_Investment_Conference_Website

Vancouver Resource Investment Conference (VRIC)

Dimanche, janvier 19, 2020 - 08:00 - Lundi, janvier 20, 2020 - 18:00
01_20_CannaTech_Davos_2020_Website

CannaTech Davos 2020

Lundi, janvier 20, 2020 (Jour entier) - Vendredi, janvier 24, 2020 (Jour entier)
01_20_4th_Annual_Groundup_Networking_Reception_Website

4th Annual Groundup Networking Reception

Lundi, janvier 20, 2020 -
16:00 - 19:00